Upload
Featured Recent Articles Topics Login Upload

Search Results for '3tc-Tdf'

3tc-Tdf published presentations and documents on DocSlides.

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
by jacey
1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...
LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in
LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in
by lucy
Virologically. Suppressed. OLE Trial. LPV-RTV + ....
Switch to DTG/3TC TANGO Design
Switch to DTG/3TC TANGO Design
by lam
Endpoints. Primary: proportion of patients with HI...
Switch to LPV/ r + 3TC OLE
Switch to LPV/ r + 3TC OLE
by susan2
Study. LPV/. r. bid + 3TC or FTC . qd. + NRTI. N ...
Switch a ATV/r 3TC Estudio ATLAS-M
Switch a ATV/r 3TC Estudio ATLAS-M
by pamella-moone
ATV/r 300/100 mg QD 3TC 300 mg QD. N = 133. N =...
Switch to DTG/ABC/3TC
Switch to DTG/ABC/3TC
by karlyn-bohler
STRIIVING . Study. Design. Endpoints. Primary: pr...
ClinicalTrials.gov
ClinicalTrials.gov
by lauren
Identifier: . NCT02770508 . Dual therapy based on ...
HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO
HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO
by hazel
Dr Laura Oyiengo. NATIONAL AIDS STI CONTROL PROGRA...
CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY
CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY
by sophie
Y. . S. un, J. Li, J. Ma, C. Wang, F. Bai, K. Zhao...
ADDP Training Programme Community Retail Pharmacy Drug Distribution Points
ADDP Training Programme Community Retail Pharmacy Drug Distribution Points
by jocelyn
(CRPDDP). Training Contents. Module 1. : . HIV Ove...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Treatment Approaches to Achieve the 2
Treatment Approaches to Achieve the 2
by gabriella
nd. 90: Child Friendly Formulations . Victor Mu...
Monday, 23 July, 10:15-12:15
Monday, 23 July, 10:15-12:15
by della
Hall 11B, RAI Amsterdam. Uptake and Procurement of...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
Treatment of Children and Adolescents
Treatment of Children and Adolescents
by liane-varnes
Implementation Challenges. Annette H. Sohn, MD. T...
ART Initiation in Resource-Limited Settings
ART Initiation in Resource-Limited Settings
by lois-ondreau
Susan M. Graham . Assistant Professor, Medicine a...
Switch to LPV/
Switch to LPV/
by lindy-dunigan
r. + 3TC. OLE . Study. LPV/. r. bid + 3TC or FT...
Rationalizing Pediatric ARV Formularies:
Rationalizing Pediatric ARV Formularies:
by marina-yarberry
The IATT Optimal Pediatric ARV List. . Presented...
Young person with multi-class resistance: follow-up and man
Young person with multi-class resistance: follow-up and man
by luanne-stotts
(with perspectives from well-resourced and resour...
Updates on Individual and Universal HIV Treatment Strategies
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine
Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine
by kylie
STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...
DTG vs LPV/r (DAWNING): Efficacy
DTG vs LPV/r (DAWNING): Efficacy
by winnie
by Baseline NRTI Resistance . and Second-Line NRTI...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
Cases From the Clinic( ians
Cases From the Clinic( ians
by ImNotABaby
):. Antiretroviral Therapy Cases . and . Panel Dis...
HIV History successes and lessons learned
HIV History successes and lessons learned
by linda
PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...
Fixed Dose Combination Anti-retroviral Drugs
Fixed Dose Combination Anti-retroviral Drugs
by dudeja
had . Comparable Immunological. , . Virological. ...
Non-Aids related co-morbidities
Non-Aids related co-morbidities
by disclaimercanon
Godelieve. de Bree. Internist-. infectiologist. ,...
1 Queen Mary University, London, United Kingdom;
1 Queen Mary University, London, United Kingdom;
by trish-goza
1 Queen Mary University, London, United Kingdom; ...
New Drugs in Development
New Drugs in Development
by marina-yarberry
New Drugs in Development Are We Ready for Long-Ac...
Dolutegravir monotherapy
Dolutegravir monotherapy
by alexa-scheidler
Dolutegravir monotherapy vs. dolutegravir/ abac...
Workshop on ART in Pregnancy, Breastfeeding, and Beyond
Workshop on ART in Pregnancy, Breastfeeding, and Beyond
by celsa-spraggs
Johannesburg, South Africa. June 18-20, 2012. HIV...
PR actical A ntiretroviral
PR actical A ntiretroviral
by tatyana-admore
M. edications. in . Paediatrics. Dr Leon J. Levi...
ARV Procurement and Value For Money
ARV Procurement and Value For Money
by marina-yarberry
Cameroon Perspectives . IAS, Paris 23 July, . 201...
B asics of A ntiretroviral
B asics of A ntiretroviral
by yoshiko-marsland
T. herapy (ART) & Management of HIV positive...
Efficacy of initial combination
Efficacy of initial combination
by natalia-silvester
antiretroviral therapy for HIV-1:. a meta-analysi...
Critical issues for Adults with
Critical issues for Adults with
by jane-oiler
HIV: Presentation . of Systematic reviews and Mai...
Updated WHO Treatment Guidelines &
Updated WHO Treatment Guidelines &
by mitsue-stanley
Data . from other . cohorts and . regions to guid...
Dual Antiretroviral Therapy
Dual Antiretroviral Therapy
by debby-jeon
This program will include a discussion of off-lab...
Projecting the Impact of
Projecting the Impact of
by marina-yarberry
Generic. HIV . Drugs. on 90-90-90. Esteban Burr...
The (HA)ART of the Matter
The (HA)ART of the Matter
by tatyana-admore
Alison Galdys, MD. ID Clinical Case Conference. 2...